In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d

Lawrence H Greenblatt

doi:10.7326/J22-0109

In type 2 diabetes, the BT-001 smartphone app reduced HbA_1c more than a control app at 90 d

Ann Intern Med. 2023 Jan;176(1):JC10. doi: 10.7326/J22-0109. Epub 2023 Jan 3.

Author

Lawrence H Greenblatt¹

Affiliation

¹ Duke University School of Medicine, Durham, North Carolina, USA (L.H.G.).

PMID: 36592462
DOI: 10.7326/J22-0109

Abstract

Hsia J, Guthrie NL, Lupinacci P, et al. Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes. Diabetes Care. 2022;45:2976-81. 36181554.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Adult
Diabetes Mellitus, Type 2* / drug therapy
Humans
Mobile Applications*